United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 11, 2026 · Filed Sep 14, 2026

On Sep 11, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$500.82 for US$4.76M under a trading plan, leaving 324,443 shares. Filed Sep 14, 2026 (Form 4).

Sold
9,500 shares
Price
US$500.82 average (US$496.74 to US$508.21)
Value
US$4.76M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 11, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 11, 2026Common StockSale1,341US$496.74332,602Indirect
Sep 11, 2026Common StockSale2,138US$497.99330,464Indirect
Sep 11, 2026Common StockSale1,021US$498.97329,443Indirect
Sep 11, 2026Common StockSale204US$499.61329,239Indirect
Sep 11, 2026Common StockSale476US$500.86328,763Indirect
Sep 11, 2026Common StockSale1,560US$502.13327,203Indirect
Sep 11, 2026Common StockSale850US$503.10326,353Indirect
Sep 11, 2026Common StockSale710US$503.99325,643Indirect
Sep 11, 2026Common StockSale82US$504.97325,561Indirect
Sep 11, 2026Common StockSale518US$506.44325,043Indirect
Sep 11, 2026Common StockSale320US$507.31324,723Indirect
Sep 11, 2026Common StockSale280US$508.21324,443Indirect

Source

View original at SEC

Related